EnteroBiotix

Bellshill, United Kingdom · Founded 2017 · Privately Held (backing)

Developer of microbiome-modulating drugs designed to restore health and prevent bacterial infections. EnteroBiotix is based in Bellshill, United Kingdom and was founded in 2017. Its last reported valuation was $66.8 million in Mar 2024. It has raised $94.2 million across 6 recorded rounds; the latest was a $5.3 million early-stage round in Mar 2026.

Last reported valuation
$66.8M
Oct 2026
Priced at
—
Total raised
$94.2M
Last round
Early Stage VC
Mar 2026

Who backs EnteroBiotix?

20 investors
InvestorType
Innovate UKOther
Scottish EnterpriseGrowth equity
SyndicateRoomVenture capital
The Scottish National Investment BankOther
Bank Workers CharityOther
University of Aberdeen EndowmentOther
Equity Gap—
Gabriel Investment Syndicate—
Hfd—
Iain Baird—
+ 10 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

EnteroBiotix investors

20 investors are on record for EnteroBiotix, including Innovate UK, Scottish Enterprise, SyndicateRoom and The Scottish National Investment Bank. The early-stage round in Mar 2026 drew 6 investors.

Free account
More of EnteroBiotix with a free account
  • ·The complete investor list: 20 names
  • ·Watch EnteroBiotix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 20 firms already write checks for companies like EnteroBiotix. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View